140 related articles for article (PubMed ID: 37437377)
1. Sodium Danshensu stabilizes atherosclerotic vulnerable plaques by targeting IKKβ mediated inflammation in macrophages.
Zeng M; Zhang X; Lv N; Wang L; Suo Y; Gan J; Yang L; Yu B; Jiang X; Zeng W
Biomed Pharmacother; 2023 Sep; 165():115153. PubMed ID: 37437377
[TBL] [Abstract][Full Text] [Related]
2. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.
Huang R; Sun Y; Liu R; Zhu B; Zhang H; Wu H
J Ethnopharmacol; 2024 Jun; 327():117969. PubMed ID: 38437888
[TBL] [Abstract][Full Text] [Related]
3. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
4. Yang-Xin-Shu-Mai granule alleviates atherosclerosis by regulating macrophage polarization via the TLR9/MyD88/NF-κB signaling pathway.
Huang H; Sun Z; Xu J; Wang L; Zhao J; Li J; Zhang S; Yuan F; Liu M; Fang Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116868. PubMed ID: 37454749
[TBL] [Abstract][Full Text] [Related]
5. Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses.
Huang Z; Shen S; Han X; Li W; Luo W; Lin L; Xu M; Wang Y; Huang W; Wu G; Liang G
EMBO Mol Med; 2023 May; 15(5):e17198. PubMed ID: 36896602
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice.
Feng X; Du M; Li S; Zhang Y; Ding J; Wang J; Wang Y; Liu P
Phytomedicine; 2023 Apr; 112():154684. PubMed ID: 36738477
[TBL] [Abstract][Full Text] [Related]
7. Costunolide alleviates atherosclerosis in high-fat diet-fed ApoE
Huang ZQ; Luo W; Li WX; Chen P; Wang Z; Chen RJ; Wang Y; Huang WJ; Liang G
Acta Pharmacol Sin; 2023 Jan; 44(1):58-70. PubMed ID: 35710877
[TBL] [Abstract][Full Text] [Related]
8. HIV Protein Tat Induces Macrophage Dysfunction and Atherosclerosis Development in Low-Density Lipoprotein Receptor-Deficient Mice.
Meng Z; Hernandez R; Liu J; Gwag T; Lu W; Hsiai TK; Kaul M; Zhou T; Zhou C
Cardiovasc Drugs Ther; 2022 Apr; 36(2):201-215. PubMed ID: 33459922
[TBL] [Abstract][Full Text] [Related]
9. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
[TBL] [Abstract][Full Text] [Related]
10. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
[TBL] [Abstract][Full Text] [Related]
11. miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE
Peng Q; Yin R; Zhu X; Jin L; Wang J; Pan X; Ma A
J Physiol Biochem; 2022 May; 78(2):365-375. PubMed ID: 35079982
[TBL] [Abstract][Full Text] [Related]
12. Muscone inhibits the progression of atherosclerotic plaques in mice aorta by inhibiting the NF-κB/p65 pathway.
Li L; Zhuang S; Jiang S
Biochem Biophys Res Commun; 2024 Apr; 702():149628. PubMed ID: 38335704
[TBL] [Abstract][Full Text] [Related]
13. Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques.
Shao X; Zeng W; Wang Q; Liu S; Guo Q; Luo D; Luo Q; Wang D; Wang L; Zhang Y; Diao H; Piao S; Yan M; Guo J
J Ethnopharmacol; 2024 Apr; 324():117705. PubMed ID: 38219878
[TBL] [Abstract][Full Text] [Related]
14. Silencing of Non-POU-domain-containing octamer-binding protein stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice via NF-κB signaling pathway.
Zhang K; Zhang F; Yang JM; Kong J; Meng X; Zhang M; Zhang C; Zhang Y
Int J Cardiol; 2018 Jul; 263():96-103. PubMed ID: 29673854
[TBL] [Abstract][Full Text] [Related]
15. Artesunate attenuates atherosclerosis by inhibiting macrophage M1-like polarization and improving metabolism.
Wang X; Du H; Li X
Int Immunopharmacol; 2022 Jan; 102():108413. PubMed ID: 34891003
[TBL] [Abstract][Full Text] [Related]
16. Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role.
Fu J; Xu H; Wu F; Tu Q; Dong X; Xie H; Cao Z
Int J Cardiol; 2022 Nov; 367():56-62. PubMed ID: 35931206
[TBL] [Abstract][Full Text] [Related]
17. Nuanxinkang protects against ischemia/reperfusion-induced heart failure through regulating IKKβ/IκBα/NF-κB-mediated macrophage polarization.
Dong X; Jiang J; Lin Z; Wen R; Zou L; Luo T; Guan Z; Li X; Wang L; Lu L; Li H; Huang Y; Yang Z; Wang J; Ye X; Hong X; Wang L; Xian S; Chen Z
Phytomedicine; 2022 Jul; 101():154093. PubMed ID: 35447422
[TBL] [Abstract][Full Text] [Related]
18.
Fang S; Sun S; Cai H; Zou X; Wang S; Hao X; Wan X; Tian J; Li Z; He Z; Huang W; Liang C; Zhang Z; Yang L; Tian J; Yu B; Sun B
Theranostics; 2021; 11(19):9358-9375. PubMed ID: 34646375
[No Abstract] [Full Text] [Related]
19. Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent.
Hao D; Danbin W; Maojuan G; Chun S; Bin L; Lin Y; Yingxin S; Guanwei F; Yefei C; Qing G; Xijuan J
Pharmacol Res; 2019 Aug; 146():104306. PubMed ID: 31181336
[TBL] [Abstract][Full Text] [Related]
20. Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway.
Chang S; Zhang G; Li L; Li H; Jin X; Wang Y; Li B
Atherosclerosis; 2023 May; 373():29-37. PubMed ID: 37121164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
